Novocure Gmbh
Clinical trials sponsored by Novocure Gmbh, explained in plain language.
A medical device company developing tumor-treating electric fields for cancer therapy.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Brain cancer patients get new hope: electric fields plus immunotherapy tested in major trial
Disease control Recruiting nowThis study tests whether adding an immunotherapy drug (pembrolizumab) to standard treatment (tumor-treating electric fields plus chemotherapy) helps people with newly diagnosed glioblastoma live longer. About 741 adults who have had surgery for glioblastoma will be randomly assig…
Phase: PHASE3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Electric field therapy device takes on metastatic lung cancer in major trial
Disease control Recruiting nowThis Phase 3 trial tests whether adding a wearable device that delivers electric fields (TTFields) to standard immunotherapy and chemotherapy improves survival in people with metastatic non-small cell lung cancer. About 734 participants who have not had prior treatment for their …
Phase: PHASE3 • Sponsor: NovoCure GmbH • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC